Fig. 1From: Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomesSchematic depiction of the main biochemical and clinical effects of DPP4 (dipeptidyl peptidase-4) inhibition. While both the increasing (green arrows) and decreasing (blue arrows) effects seem to be favorable, the overall influence on MACE (major adverse cardiovascular events) remains uncertainBack to article page